Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Show me how to use this page

Dexcom Inc. Stock

Price
Target price
€77.20

€77.20

-0.520%
-0.4
-0.520%
€75.82
 
07:30 / Tradegate WKN: A0D9T1 / Symbol: DXCM / Name: DexCom / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Dexcom Inc. in the next few years
Wizard

Financial data and news for DexCom

sharewise wants to provide you with the best news and tools for DexCom, so we directly link to the best financial data sources.

Financials

News

Broker

 

News

DexCom Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
DexCom Q2 Earnings Call Highlights

Key Points

MarketBeat 
0 31.07.26
3 Non-Pharma Firms That Could Benefit From the GLP-1 TrendPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend

Key Points

MarketBeat 
0 20.06.26
DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor DayPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day

DexCom (NASDAQ:DXCM) used its 2026 Investor Day to outline a long-range plan centered on new product launches, broader insurance coverage for

MarketBeat 
0 16.05.26
Pediatrix Medical Group Q1 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Pediatrix Medical Group Q1 Earnings Call Highlights

Pediatrix Medical Group (NYSE:MD) reaffirmed its full-year 2026 adjusted EBITDA outlook after reporting what management described as a strong first quarter, supported

MarketBeat 
0 11.05.26
3 Reasons Analysts Love DexComPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
3 Reasons Analysts Love DexCom

While GLP-1 agonists have grabbed investor attention for their potential as weight loss aids, these medicines also form a crucial component of a broader set of tools to address type 2 diabetes

MarketBeat 
0 05.05.26
DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026?: https://cdn.content.foolcdn.com/images/1umn9qeh/production/3a7b7d740be428c35a4ad30f93004a7d655cc124-1200x800.png?w=800&q=75&fit=max&auto=format
DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026?

Diabetes management is evolving rapidly as the industry innovates to treat the more than 40 million Americans with type 1 or type 2 diabetes. Deciding between two leaders in monitoring and

TheMotleyFool 
0 04.06.26
2 Growth Stocks to Hold for the Next DecadePhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
2 Growth Stocks to Hold for the Next Decade

Over the past year, Intuitive Surgical (NASDAQ: ISRG) and DexCom (NASDAQ: DXCM) have faced headwinds, and have lagged the stock market as a result. Shares of the former are down 13% over the

TheMotleyFool 
0 10.03.26
Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 WarsPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars

Many pharmaceutical companies are looking to develop and market the now highly popular GLP-1 drugs, which help treat diabetes, help patients lose weight, and reduce their risk of a range of

TheMotleyFool 
0 25.02.26